ENDROLIN Trademark

Trademark Overview

On Thursday, June 16, 2005, a trademark application was filed for ENDROLIN with the United States Patent and Trademark Office. The USPTO has given the ENDROLIN trademark a serial number of 78652498. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 5, 2009. This trademark is owned by P.T. Kalbe Farma Tbk.. The ENDROLIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation containing leuprorelin for endometriosis and prostate cancer therapy
endrolin

General Information

Serial Number78652498
Word MarkENDROLIN
Filing DateThursday, June 16, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 5, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparation containing leuprorelin for endometriosis and prostate cancer therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 21, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameP.T. Kalbe Farma Tbk.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBekasi 17550
ID
Party NameP.T. Kalbe Farma Tbk.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBekasi 17550
ID

Trademark Events

Event DateEvent Description
Monday, October 5, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 5, 2009ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 18, 2009EXTENSION 5 GRANTED
Wednesday, February 18, 2009EXTENSION 5 FILED
Wednesday, February 18, 2009TEAS EXTENSION RECEIVED
Thursday, September 4, 2008EXTENSION 4 GRANTED
Thursday, September 4, 2008EXTENSION 4 FILED
Thursday, September 4, 2008TEAS EXTENSION RECEIVED
Monday, March 3, 2008EXTENSION 3 GRANTED
Monday, March 3, 2008EXTENSION 3 FILED
Monday, March 3, 2008TEAS EXTENSION RECEIVED
Wednesday, August 15, 2007EXTENSION 2 GRANTED
Wednesday, August 15, 2007EXTENSION 2 FILED
Wednesday, August 15, 2007TEAS EXTENSION RECEIVED
Thursday, May 10, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 1, 2007EXTENSION 1 GRANTED
Thursday, March 1, 2007EXTENSION 1 FILED
Thursday, March 1, 2007TEAS EXTENSION RECEIVED
Tuesday, September 5, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 13, 2006PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2006NOTICE OF PUBLICATION
Friday, April 21, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 14, 2006ASSIGNED TO LIE
Monday, April 10, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 3, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 13, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 13, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2006PRIORITY ACTION E-MAILED
Friday, January 13, 2006PRIORITY ACTION WRITTEN
Friday, January 6, 2006ASSIGNED TO EXAMINER
Tuesday, June 21, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

endrolin prostate cancer therapy endometriosis leuprorelin preparation containing pharmaceutical